ISCO लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (27 Apr 2024 @ 00:29):

International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in North America, Asia, Europe, and internationally...

Stats
आज की मात्रा	525.00
औसत मात्रा	1 252.00
बाजार मूल्य	489 869
EPS	$-0.0200 ( 2023-11-13 )
अगली कमाई की तारीख	( $0 ) 2024-06-11
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.06
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2023-11-06	Semechkin Andrey	Buy	500 000	Stock Option (Right to Buy)
2023-11-06	Kern Russell	Buy	2 000 000	Stock Option (Right to Buy)
2023-06-14	Don Wright	Buy	445 205	Stock Option (Right to Buy)
2023-06-14	Don Wright	Buy	30 000	Stock Option (Right to Buy)
2023-06-14	Maier Paul V	Buy	445 205	Stock Option (Right to Buy)

INSIDER POWER
100.00
Last 100 transactions
Buy: 8 687 168 \| Sell: 208 326

International Stem Cell सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

International Stem Cell वित्तीय

Annual	2023
राजस्व:	$7.79M
सकल लाभ:	$4.53M (58.11 %)
EPS:	$-0.0164

FY	2023
राजस्व:	$7.79M
सकल लाभ:	$4.53M (58.11 %)
EPS:	$-0.0164

FY	2022
राजस्व:	$8.18M
सकल लाभ:	$4.91M (60.04 %)
EPS:	$-0.0582

FY	2021
राजस्व:	$7.18M
सकल लाभ:	$4.24M (59.10 %)
EPS:	$-0.110

Financial Reports:

No articles found.

International Stem Cell

International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in North America, Asia, Europe, and internationally. The company's products are based on human parthenogenetic stem cells, a proprietary type of pluripotent stem cell. It develops various cell types, including neural stem cells for the treatment of Parkinson's disease and other central nervous system disorders; and develops, manufactures, and markets anti-aging skincare and human cell culture products. The company's human cell culture products include human skin cells and reagents for the study of skin disease, toxicology, or wound healing; human cells from the heart and blood vessels, and reagents to study cardiovascular disease and cancer; human bronchial and tracheal cell lines for the study of toxicity, cystic fibrosis, asthma, and pathogenesis; and human mammary epithelial cell lines for the study of breast cancer, three dimensional culture, and carcinogen screening. Its human cell culture products also comprise adult stem cells and reagents for regenerative medicine; human prostate cells and specialized medium to study prostate disease; human renal and bladder cells and media to study renal and bladder diseases; human corneal cells and media for the study of corneal disease; human female reproductive system cells for the study of cellular physiology; human skeletal muscle cells for the study of biology, diabetes, insulin receptor studies, muscle metabolism, muscle tissue repair, and myotube development; and other cell culture reagents and supplements for the growth, staining, and freezing of human cells. The company sells skincare products through a website and professional channels; and human cell culture products through its sales force, OEM partners, and brand distributors. International Stem Cell Corporation was founded in 2001 and is headquartered in San Diego, California.